The management of Cohance Lifesciences Limited will be attending the Ashwamedh - Elara India Dialogue 2026 conference for analyst and institutional investor interactions.
The event is scheduled for 1 September 2026 in Mumbai.
The company will participate in both group sessions and one-on-one meetings during the conference.
The stated purpose is investor engagement through conference participation, though no specific discussion topics are detailed.
The company explicitly states that no unpublished price sensitive information (UPSI) will be shared during these interactions.
The schedule is noted as subject to change due to exigencies on the part of analysts, institutional investors, or the company.
Additional Notes Section
This is a regulatory disclosure made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The disclosure was addressed to both BSE Limited and National Stock Exchange of India Limited.
The document was signed by Sisir K. Mishra, Company Secretary & Compliance Officer, on 27 August 2026.
No financial data, performance figures, guidance, or strategic updates were disclosed in this announcement.
No presentation materials, earnings decks, transcripts, or recordings were mentioned as being made available.
No specific management participants or their designations were listed in the disclosure.
